Alimentary Pharmacology & Therapeutics

management of patients with non-responsive coeliac disease
pp. 671-680(10)
Authors: O'mahony, S.; Howdle, P.D.; Losowsky, M.S.

pathogenesis and treatment of chronic hepatic encephalopathy
pp. 681-697(17)
Authors: Jalan, R.; Seery, J.P.; Taylor-Robinson, S.D.

the management of gallstone disease
pp. 699-705(7)
Author: Hussaini, S.H.

Clinical economics review: the health-care economic implications of minimal access gastrointestinal surgery
pp. 707-713(7)
Authors: Guillou, P.J.; Windsor, A.J.; Nejim, A.

The effect of a non-absorbable fat substitute, sucrose polyester, on gastrointestinal function
pp. 715-720(6)
Authors: Kelly, S.M.; Hunter, J.O.

Treatment of severe Crohn's disease with anti-CD4 monoclonal antibody
pp. 721-727(7)
Authors: Canva-delcambre, V.; Jacquot, S.; Robinet, E.; Lemann, M.; Drouet, C.; Labalette, M.; dessaint, J.P.; Engoufa, D.; Rabian, B.C.; Modigliani, R.; Wijdenes, J.; Revillard, J.P.; Colombel, J.F.

Treatment of left-sided ulcerative colitis with butyrate enemas: a controlled trial
pp. 729-736(8)
Authors: Steinhart, A.H.; Hiruki, T.; Brzezinski, A.; Baker, J.P.

Xanthine oxidase activity is not increased in the colonic mucosa of ulcerative colitis
pp. 737-741(5)
Authors: Reynolds, P.D.; Rhenius, S.T.; Hunter, J.O.

Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man
pp. 743-747(5)
Authors: Grimley, C.E.; West, J.M.; Loft, D.E.; Cottrell, J.; Mann, S.G.; Stauffer, L.; Nwokolo, C.U.

Low-dose famotidine and ranitidine as single post-prandial doses: a three-period placebo-controlled comparative trial
pp. 749-755(7)
Authors: Reilly, T.G.; Singh, S.; Cottrell, J.; Mann, S.G.; Stauffer, L.; Walt, R.P.

Rapid symptom relief in reflux oesophagitis: a comparison of lansoprazole and omeprazole
pp. 757-763(7)
Authors: Mee, A.S.; Rowley, J.L.; The Lansoprazole Clinical Research Group,

Influence of loperamide on lactose handling and oral-caecal transit time
pp. 765-770(6)
Authors: Szilagyi, A.; Salomon, R.; Seidman, E.

In vitro dissolution profiles of enteric-coated microsphere/microtablet pancreatin preparations at different pH values
pp. 771-775(5)
Authors: Gan, K.H.; Geus, W.P.; Bakker, W.; Lamers, C.B.H.W.; Heijerman, H.G.M.

A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study
pp. 777-2813(2037)
Authors: Bernstein, C.N.; Seeger, L.L.; Anton, P.A.; Artinian, L.; Geffrey, S.; Goodman, W.; Belin, T.R.; Shanahan, F.

Mebeverine alters small bowel motility in irritable bowel syndrome
pp. 787-793(7)
Authors: Evans, P.R.; Bak, Y.T.; Kellow, J.E.

Differing actions of the acute administration of propranolol and isosorbide-5-mononitrate on the portal circulation
pp. 795-800(6)
Authors: Forrest, E.H.; Jalan, R.; Redhead, D.N.; Hayes, P.C.

Clinical response after transjugular intrahepatic portosystemic stent shunt insertion for refractory ascites in cirrhosis
pp. 801-806(6)
Authors: Forrest, E.H.; Stanley, A.J.; Redhead, D.N.; McGILCHRIST, A.J.; Hayes, P.C.

Subcutaneously administered recombinant human beta-interferon in the treatment of chronic hepatitis B virus infection
pp. 807-814(8)
Authors: Guan, R.; Yeoh, K.G.; Yap, I.; Kang, J.Y.; Wee, A.; Smith, R.

The palatability of five colonic lavage solutions
pp. 815-819(5)
Authors: Diab, F.H.; Marshall, J.B.

Effects of lansoprazole plus amoxycillin on the cure of Helicobacter pylori infection in Japanese peptic ulcer patients
pp. 821-2813(1993)
Authors: Kato, M.; Asaka, M.; Kudo, M.; Sukegawa, M.; Katagiri, M.; Koshiyama, T.; Kagaya, H.; Nishikawa, K.; Hokari, K.; Takeda, H.; Sugiyama, T.

Omeprazole versus ranitidine: short-term triple-therapy in patients with Helicobacter pylori-positive duodenal ulcers
pp. 829-831(3)
Authors: Spadaccini, A.; de Fanis, C.; Sciampa, G.; Masciulli, V.; Pantaleone, U.; Di Virgili, M.; Magnarini, C.; Pizzicannella, G.